339 related articles for article (PubMed ID: 26371246)
1. The Levels of the Lectin Pathway Serine Protease MASP-1 and Its Complex Formation with C1 Inhibitor Are Linked to the Severity of Hereditary Angioedema.
Hansen CB; Csuka D; Munthe-Fog L; Varga L; Farkas H; Hansen KM; Koch C; Skjødt K; Garred P; Skjoedt MO
J Immunol; 2015 Oct; 195(8):3596-604. PubMed ID: 26371246
[TBL] [Abstract][Full Text] [Related]
2. Activation of the ficolin-lectin pathway during attacks of hereditary angioedema.
Csuka D; Munthe-Fog L; Hein E; Zotter Z; Prohászka Z; Farkas H; Varga L; Garred P
J Allergy Clin Immunol; 2014 Dec; 134(6):1388-1393.e1. PubMed ID: 25042985
[TBL] [Abstract][Full Text] [Related]
3. The role of ficolins and MASPs in hereditary angioedema due to C1-inhibitor deficiency.
Csuka D; Munthe-Fog L; Skjoedt MO; Kocsis A; Zotter Z; Gál P; Varga L; Farkas H; Füst G; Garred P
Mol Immunol; 2013 Jul; 54(3-4):271-7. PubMed ID: 23318225
[TBL] [Abstract][Full Text] [Related]
4. Possible disease-modifying factors: the mannan-binding lectin pathway and infections in hereditary angioedema of children and adults.
Cedzyński M; Madaliński K; Gregorek H; Swierzko AS; Nowicka E; Obtułowicz K; Dzierzanowska-Fangrat K; Wojda U; Rabczenko D; Kawakami M
Arch Immunol Ther Exp (Warsz); 2008; 56(1):69-75. PubMed ID: 18250972
[TBL] [Abstract][Full Text] [Related]
5. Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients.
Kajdácsi E; Jandrasics Z; Veszeli N; Makó V; Koncz A; Gulyás D; Köhalmi KV; Temesszentandrási G; Cervenak L; Gál P; Dobó J; de Maat S; Maas C; Farkas H; Varga L
Front Immunol; 2020; 11():794. PubMed ID: 32431708
[TBL] [Abstract][Full Text] [Related]
6. Plasma-derived mannose-binding lectin shows a direct interaction with C1-inhibitor.
Keizer MP; Kamp AM; Brouwer N; van de Wetering MD; Wouters D; Kuijpers TW
Mol Immunol; 2014 Apr; 58(2):187-93. PubMed ID: 24368318
[TBL] [Abstract][Full Text] [Related]
7. Coagulation Factor XII Gene Mutation in Brazilian Families with Hereditary Angioedema with Normal C1 Inhibitor.
Moreno AS; Valle SO; Levy S; França AT; Serpa FS; Arcuri HA; Palma MS; Campos WN; Dias MM; Ponard D; Monnier N; Lunardi J; Bork K; Silva WA; Arruda LK
Int Arch Allergy Immunol; 2015; 166(2):114-20. PubMed ID: 25790805
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
Kaplan AP; Joseph K
Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
[TBL] [Abstract][Full Text] [Related]
9. High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency.
Suffritti C; Zanichelli A; Maggioni L; Bonanni E; Cugno M; Cicardi M
Clin Exp Allergy; 2014 Dec; 44(12):1503-14. PubMed ID: 24552232
[TBL] [Abstract][Full Text] [Related]
10. A novel assay to quantitate MASP-2/ficolin-3 complexes in serum.
Csuka D; Munthe-Fog L; Skjoedt MO; Hein E; Bay JT; Varga L; Füst G; Garred P
J Immunol Methods; 2013 Jan; 387(1-2):237-44. PubMed ID: 23142462
[TBL] [Abstract][Full Text] [Related]
11. C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema.
Madsen DE; Sidelmann JJ; Biltoft D; Gram J; Hansen S
Biochim Biophys Acta; 2015 Jun; 1850(6):1336-42. PubMed ID: 25800206
[TBL] [Abstract][Full Text] [Related]
12. Distinction of early complement classical and lectin pathway activation
Hurler L; Toonen EJM; Kajdácsi E; van Bree B; Brandwijk RJMGE; de Bruin W; Lyons PA; Bergamaschi L; ; Sinkovits G; Cervenak L; Würzner R; Prohászka Z
Front Immunol; 2022; 13():1039765. PubMed ID: 36420270
[TBL] [Abstract][Full Text] [Related]
13. Presence of C1-inhibitor polymers in a subset of patients suffering from hereditary angioedema.
Madsen DE; Hansen S; Gram J; Bygum A; Drouet C; Sidelmann JJ
PLoS One; 2014; 9(11):e112051. PubMed ID: 25369003
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis and laboratory diagnosis of hereditary angioedema.
Zuraw BL; Christiansen SC
Allergy Asthma Proc; 2009; 30(5):487-92. PubMed ID: 19843402
[TBL] [Abstract][Full Text] [Related]
15. Complement factor C4 activation in patients with hereditary angioedema.
Aabom A; Bygum A; Koch C
Clin Biochem; 2017 Oct; 50(15):816-821. PubMed ID: 28412283
[TBL] [Abstract][Full Text] [Related]
16. Baseline level of functional C1-inhibitor correlates with disease severity scores in hereditary angioedema.
Kelemen Z; Moldovan D; Mihály E; Visy B; Széplaki G; Csuka D; Füst G; Farkas H; Varga L
Clin Immunol; 2010 Mar; 134(3):354-8. PubMed ID: 19945350
[TBL] [Abstract][Full Text] [Related]
17. Parameters of the classical complement pathway predict disease severity in hereditary angioedema.
Csuka D; Füst G; Farkas H; Varga L
Clin Immunol; 2011 Apr; 139(1):85-93. PubMed ID: 21300570
[TBL] [Abstract][Full Text] [Related]
18. Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, C1-inhibitor.
Kerr FK; Thomas AR; Wijeyewickrema LC; Whisstock JC; Boyd SE; Kaiserman D; Matthews AY; Bird PI; Thielens NM; Rossi V; Pike RN
Mol Immunol; 2008 Feb; 45(3):670-7. PubMed ID: 17709141
[TBL] [Abstract][Full Text] [Related]
19. Paternal mosaicism and hereditary angioedema in a Taiwanese family.
Yu TC; Shyur SD; Huang LH; Wen DC; Li JS
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):375-9. PubMed ID: 17941288
[TBL] [Abstract][Full Text] [Related]
20. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.
Farkas H; Jakab L; Temesszentandrási G; Visy B; Harmat G; Füst G; Széplaki G; Fekete B; Karádi I; Varga L
J Allergy Clin Immunol; 2007 Oct; 120(4):941-7. PubMed ID: 17761272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
